We are live on ! Find out more
STRO icon

Sutro Biopharma
STRO

134 hedge funds and large institutions have $819M invested in Sutro Biopharma in 2020 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 45 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

369% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 13

200% more funds holding in top 10

Funds holding in top 10: 2 → 6 (+4)

169% more capital invested

Capital invested by funds: $304M → $819M (+$515M)

150% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 18

96% more call options, than puts

Call options by funds: $1.5M | Put options by funds: $763K

56% more funds holding

Funds holding: 86 → 134 (+48)

0.14% more ownership

Funds ownership: 8.51% → 8.66% (+0.14%)

Holders
134
Holders Change
+48
Holders Change %
+55.81%
% of All Funds
2.37%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.11%
New
61
Increased
45
Reduced
18
Closed
13
Calls
$1.5M
Puts
$763K
Net Calls
+$732K
Net Calls Change
+$732K

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$36.9M
2
Holocene Advisors
Holocene Advisors
New York
+$17.7M
3
FM
Frazier Management
Washington
+$16.6M
4
FLAM
First Light Asset Management
Minnesota
+$13.7M
5
BlackRock
BlackRock
New York
+$11.1M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$50M
2
BI
BVF Inc
California
-$20.4M
3
CCM
Camber Capital Management
Massachusetts
-$6.03M
4
ECM
Endurant Capital Management
California
-$4.8M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$4.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
51
Pinz Capital Management
New York
$2.99M +$2.28M +13,780 New
SSA
52
Schonfeld Strategic Advisors
New York
$2.98M +$1.43M +8,623 +169%
Goldman Sachs
53
Goldman Sachs
New York
$2.88M +$1.9M +11,473 +632%
Federated Hermes
54
Federated Hermes
Pennsylvania
$2.86M +$2.18M +13,180 New
Morgan Stanley
55
Morgan Stanley
New York
$2.86M +$2.01M +12,131 +1,177%
Neuberger Berman Group
56
Neuberger Berman Group
New York
$2.64M +$2.01M +12,150 New
EGI
57
EAM Global Investors
California
$2.62M +$2M +12,079 New
Acadian Asset Management
58
Acadian Asset Management
Massachusetts
$2.61M -$112K -675 -5%
Deutsche Bank
59
Deutsche Bank
Germany
$2.54M +$1.7M +10,274 +726%
Bank of New York Mellon
60
Bank of New York Mellon
New York
$2.19M +$653K +3,946 +64%
D.E. Shaw & Co
61
D.E. Shaw & Co
New York
$2.14M +$1.63M +9,863 New
Dimensional Fund Advisors
62
Dimensional Fund Advisors
Texas
$2.14M +$1.63M +9,855 New
EC
63
EcoR1 Capital
California
$2.03M -$50M -302,020 -97%
EI
64
EAM Investors
California
$1.86M +$1.42M +8,553 New
DCM
65
DAFNA Capital Management
California
$1.84M -$562K -3,394 -29%
MIM
66
Monashee Investment Management
Massachusetts
$1.63M +$1.24M +7,500 New
Charles Schwab
67
Charles Schwab
California
$1.52M +$72.4K +437 +7%
BFM
68
Boothbay Fund Management
New York
$1.48M +$277K +1,672 +32%
Invesco
69
Invesco
Georgia
$1.46M +$1.11M +6,719 New
JP Morgan Chase
70
JP Morgan Chase
New York
$1.45M -$96.2K -581 -8%
PAM
71
Panagora Asset Management
Massachusetts
$1.42M +$407K +2,461 +60%
AG
72
Algert Global
California
$1.4M +$1.06M +6,425 New
SFI
73
Susquehanna Fundamental Investments
Pennsylvania
$1.38M +$356K +2,152 +51%
HS
74
HighVista Strategies
Massachusetts
$1.37M -$27.2K -164 -3%
Wells Fargo
75
Wells Fargo
California
$1.36M +$282K +1,706 +37%
1 2
3
4 5

STRO Hedge Fund Activity: Q4 2020 in Review

134 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Sutro Biopharma (STRO) for Q4 2020, worth a combined $819M — up 169% from $304M a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new STRO positions and 13 closed out — a net gain of 48 holders — while 45 added to existing stakes and 18 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $36.9M. The largest seller was EcoR1 Capital, cutting an estimated $50M.

  • 134 institutional investors held Sutro Biopharma (STRO) as of Q4 2020, up from 86 in Q3 2020.
  • Funds reported $819M of Sutro Biopharma stock for Q4 2020, up 169% quarter-over-quarter.
  • 61 funds opened new Sutro Biopharma positions in Q4 2020 and 13 closed out, a net change of +48 holders.
  • The largest Sutro Biopharma buyer in Q4 2020 was Franklin Resources, an estimated $36.9M added.
  • The largest Sutro Biopharma seller in Q4 2020 was EcoR1 Capital, an estimated $50M sold.

Based on aggregated 13F filings for Q4 2020.